MSDx: A Novel Approach for CNS Biomarkers

MSDx Biomarkers for CNS Disease

By: Ramesh C. Nayak

Blood Based Biochemical Monitoring of Major Diseases of the CNS
In the vast majority of diseases of the CNS there are no blood tests to aid in the diagnosis and long-term management of patients. Consequently, there is a pressing clinical need for inexpensive blood tests that allow the physician to closely monitor the physiological status of patients with CNS disease/injury and their response to disease-modifying therapies. To produce tests that provide critical and timely information requires biomarkers that are involved in the disease mechanism. That requires an understanding of how the disease process evolves over time so that key processes can be monitored.